These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23615556)

  • 41. FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
    Pardanani A; Ketterling RP; Li CY; Patnaik MM; Wolanskyj AP; Elliott MA; Camoriano JK; Butterfield JH; Dewald GW; Tefferi A
    Leuk Res; 2006 Aug; 30(8):965-70. PubMed ID: 16406016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypereosinophilic syndrome in the tyrosine kinase inhibitor era.
    Takahashi N
    Intern Med; 2015; 54(6):551-2. PubMed ID: 25786442
    [No Abstract]   [Full Text] [Related]  

  • 43. FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis.
    Gilliland G; Cools J; Stover EH; Wlodarska I; Marynen P
    Hematol J; 2004; 5 Suppl 3():S133-7. PubMed ID: 15190295
    [No Abstract]   [Full Text] [Related]  

  • 44. Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma.
    Metzgeroth G; Walz C; Score J; Siebert R; Schnittger S; Haferlach C; Popp H; Haferlach T; Erben P; Mix J; Müller MC; Beneke H; Müller L; Del Valle F; Aulitzky WE; Wittkowsky G; Schmitz N; Schulte C; Müller-Hermelink K; Hodges E; Whittaker SJ; Diecker F; Döhner H; Schuld P; Hehlmann R; Hochhaus A; Cross NC; Reiter A
    Leukemia; 2007 Jun; 21(6):1183-8. PubMed ID: 17377585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.
    Cools J
    Verh K Acad Geneeskd Belg; 2005; 67(3):169-76. PubMed ID: 16089297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.
    Thota NK; Gundeti S; Linga VG; Coca P; Tara RP;
    Indian J Cancer; 2014; 51(1):5-9. PubMed ID: 24947087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Charcot-Leyden crystals in the trephine biopsy of a patient with a FIP1L1-PDGFRA - positive myeloproliferative disorder.
    Lyall H; O'Connor S; Clark D
    Br J Haematol; 2007 Aug; 138(4):405. PubMed ID: 17593250
    [No Abstract]   [Full Text] [Related]  

  • 48. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
    Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
    Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.
    Pardanani A; Lasho T; Barraco D; Patnaik M; Elala Y; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):E10-1. PubMed ID: 26663400
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term follow-up of FIP1L1-PDGFRA-mutated patients with eosinophilia: survival and clinical outcome.
    Pardanani A; D'Souza A; Knudson RA; Hanson CA; Ketterling RP; Tefferi A
    Leukemia; 2012 Nov; 26(11):2439-41. PubMed ID: 22705991
    [No Abstract]   [Full Text] [Related]  

  • 51. The hypereosinophilic syndrome: idiopathic or not, that is the question.
    Cools J
    Haematologica; 2005 May; 90(5):582-4. PubMed ID: 15921372
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of systemic mast cell disease: beyond interferon.
    Tefferi A
    Leuk Res; 2004 Mar; 28(3):223-4. PubMed ID: 14687615
    [No Abstract]   [Full Text] [Related]  

  • 53. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.
    Tefferi A; Gotlib J; Pardanani A
    Mayo Clin Proc; 2010 Feb; 85(2):158-64. PubMed ID: 20053713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature.
    Socola F; Hawes V; Lobo RH; Sasapu A
    J Glob Oncol; 2018 Sep; 4():1-4. PubMed ID: 30241197
    [No Abstract]   [Full Text] [Related]  

  • 55. A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes.
    Intermesoli T; Delaini F; Acerboni S; Salmoiraghi S; Spinelli O; Guerini V; Vannucchi AM; Mappa S; Rossi G; Rossi V; Di Bona E; Paratore S; Carobbio A; Rambaldi A; Barbui T; Bassan R
    Br J Haematol; 2009 Dec; 147(5):681-5. PubMed ID: 19735261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
    La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
    Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of hypereosinophilic syndrome presenting with chronic cough successfully treated with imatinib.
    Kobayashi M; Kubota T; Uemura Y; Taguchi H
    Respirology; 2009 Mar; 14(2):302-4. PubMed ID: 19192229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Disorders with eosinophilia, treatment of hypereosinophilic syndrome].
    Borbényi Z
    Orv Hetil; 2005 May; 146(18 Suppl 1):911-6. PubMed ID: 15921304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Two patients with hypereosinophilic syndrome].
    van Ruth S; Lokhorst HM; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2006 May; 150(21):1193-7. PubMed ID: 16768285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of
    Baer C; Muehlbacher V; Kern W; Haferlach C; Haferlach T
    Haematologica; 2018 Aug; 103(8):e348-e350. PubMed ID: 29567772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.